These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2297705)

  • 21. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
    Fernandez-Pol JA; Klos DJ; Grant GA
    Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer.
    Foekens JA; Portengen H; van Putten WL; Trapman AM; Reubi JC; Alexieva-Figusch J; Klijn JG
    Cancer Res; 1989 Dec; 49(24 Pt 1):7002-9. PubMed ID: 2555057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presence of heparin binding growth factor in mouse bladder tumors and urine from mice with bladder cancer.
    Chodak GW; Shing Y; Borge M; Judge SM; Klagsbrun M
    Cancer Res; 1986 Nov; 46(11):5507-10. PubMed ID: 3756899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
    Arteaga CL; Tandon AK; Von Hoff DD; Osborne CK
    Cancer Res; 1988 Jul; 48(14):3898-904. PubMed ID: 3164252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of growth factors in human ovarian carcinomas.
    Bauknecht T; Kiechle M; Bauer G; Siebers JW
    Cancer Res; 1986 May; 46(5):2614-8. PubMed ID: 3008995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo toxicity, pharmacokinetics, and anticancer activity of Genistein linked to recombinant human epidermal growth factor.
    Uckun FM; Narla RK; Zeren T; Yanishevski Y; Myers DE; Waurzyniak B; Ek O; Schneider E; Messinger Y; Chelstrom LM; Gunther R; Evans W
    Clin Cancer Res; 1998 May; 4(5):1125-34. PubMed ID: 9607569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bladder epithelial cells from patients with interstitial cystitis produce an inhibitor of heparin-binding epidermal growth factor-like growth factor production.
    Keay S; Kleinberg M; Zhang CO; Hise MK; Warren JW
    J Urol; 2000 Dec; 164(6):2112-8. PubMed ID: 11061938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of transforming growth factors produced by the insulin-independent teratoma-derived cell line 1246-3A.
    Yamada Y; Serrero G
    J Cell Physiol; 1989 Aug; 140(2):254-63. PubMed ID: 2663884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and secretion of an hEGF-like immunoreactive factor by human gastric cancer cells (MKN-45).
    Mori K; Ibaragi S; Kurobe M; Furukawa S; Hayashi K
    Biochem Int; 1987 May; 14(5):779-85. PubMed ID: 3502641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transferrin as a growth factor for rat bladder carcinoma cells in culture.
    Hayashi O; Noguchi S; Oyasu R
    Cancer Res; 1987 Sep; 47(17):4560-4. PubMed ID: 3621154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of prostatic growth factor, basic fibroblast growth factor, epidermal growth factor, and steroids on the proliferation of human fetal prostatic fibroblasts.
    Luo D; Lin Y; Liu X; Qin Z; Zhao C; Zhang Y; Yu Z
    Prostate; 1996 Jun; 28(6):352-8. PubMed ID: 8650071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of human lung epithelial cell growth factors produced by a lung carcinoma cell line: use in culture of primary solid lung tumors.
    Siegfried JM
    Cancer Res; 1987 Jun; 47(11):2903-10. PubMed ID: 3032416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Rapid isolation of highly purified epidermal growth factor by reverse-phase liquid chromatography].
    Ivashchenko IuD; Osipova LA; Gut IT; Garmanchuk LV
    Eksp Onkol; 1985; 7(6):47-9. PubMed ID: 3878774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transforming growth factors in solid human malignant neoplasms.
    Nickell KA; Halper J; Moses HL
    Cancer Res; 1983 May; 43(5):1966-71. PubMed ID: 6299535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxic activity of epidermal growth factor-genistein against breast cancer cells.
    Uckun FM; Narla RK; Jun X; Zeren T; Venkatachalam T; Waddick KG; Rostostev A; Myers DE
    Clin Cancer Res; 1998 Apr; 4(4):901-12. PubMed ID: 9563884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transforming growth factor (TGF) activity in human urine: synergism between TGF-beta and urogastrone.
    Twardzik DR; Sherwin SA
    J Cell Biochem; 1985; 28(4):289-97. PubMed ID: 2997242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bladder stretch alters urinary heparin-binding epidermal growth factor and antiproliferative factor in patients with interstitial cystitis.
    Chai TC; Zhang CO; Shoenfelt JL; Johnson HW; Warren JW; Keay S
    J Urol; 2000 May; 163(5):1440-4. PubMed ID: 10751853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.
    Ram TG; Dilts CA; Dziubinski ML; Pierce LJ; Ethier SP
    Mol Carcinog; 1996 Mar; 15(3):227-38. PubMed ID: 8597535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transforming growth factor release by human tumor cell lines and their interactions with other growth factors.
    Rueda F; Piñol G; Gonzalez-Garrigues M; Marti F; Fabra A
    Anticancer Res; 1989; 9(4):1245-8. PubMed ID: 2683995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of phorbol ester on epidermal growth factor receptors in estrogen receptor-positive and -negative breast cancer cell lines.
    Koga M; Musgrove EA; Sutherland RL
    Cancer Res; 1990 Aug; 50(16):4849-55. PubMed ID: 2379149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.